Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Formycon AG

Start price
Target price
Perf. (%)
€67.20
08.02.21
-
08.02.22
-19.79%
09.02.22

buy
Formycon AG

Start price
Target price
Perf. (%)
€67.40
07.02.21
€80.00
07.02.22
-20.03%
08.02.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
High valuation
Low dividend yield expected
buy
Bayer AG

Start price
Target price
Perf. (%)
€56.11
05.02.21
€90.00
05.02.22
-5.54%
05.02.22

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Rising EBIT margin expected
Fresenius SE & Co. KGaA

Start price
Target price
Perf. (%)
€33.80
02.02.21
€30.00
16.02.21
0.27%
02.02.21

buy
Fresenius SE & Co. KGaA

Start price
Target price
Perf. (%)
€36.24
01.02.21
€40.00
01.02.22
1.56%
01.02.22

Fresenius SE & Co. KGaA

Start price
Target price
Perf. (%)
€36.17
01.02.21
€26.00
30.06.22
-10.17%
19.05.22

Fresenius SE & Co. KGaA

Start price
Target price
Perf. (%)
€37.03
29.01.21
€34.00
29.04.21
-5.94%
08.02.21

Could be worthwhile Investment >10% per year
Fair valuation
High dividend yield expected
Small challenges to pay loans and raise capital
buy
Heidelberg Pharma AG

Start price
Target price
Perf. (%)
€5.64
27.01.21
€8.00
27.01.22
9.75%
28.09.21

Could be worthwhile Investment >10% per year
buy
Fresenius SE & Co. KGaA

Start price
Target price
Perf. (%)
€38.44
27.01.21
€45.00
27.01.22
-4.29%
28.01.22

Could be worthwhile Investment >10% per year
buy
Drägerwerk AG & Co. KGaA ST

Start price
Target price
Perf. (%)
€67.80
23.01.21
€88.00
23.01.22
-26.99%
24.01.22

Fair valuation
Top 10 in its market
Future proof or reliable business model
Could be worthwhile Investment >10% per year
buy
Drägerwerk AG & Co. KGaA VZO

Start price
Target price
Perf. (%)
€71.80
23.01.21
€88.00
23.01.22
-30.36%
24.01.22

Market Leader or Top 3
Well known brand
Very Future proof/growth oriented business model
Revenue growth > 30% per year expected
buy
Drägerwerk AG & Co. KGaA VZO

Start price
Target price
Perf. (%)
€69.30
21.01.21
-
21.01.22
17.39%
29.06.21

buy
Formycon AG

Start price
Target price
Perf. (%)
€60.40
18.01.21
€80.00
18.01.22
-9.93%
04.10.21

Could be worthwhile Investment >10% per year
buy
Merck KGaA

Start price
Target price
Perf. (%)
€144.55
11.01.21
€145.00
11.01.22
42.10%
12.09.21

Could be very worthwhile Investment >20% year
buy
Fresenius SE & Co. KGaA

Start price
Target price
Perf. (%)
€39.13
11.01.21
€50.00
11.01.22
-5.37%
29.01.21

Could be worthwhile Investment >10% per year
Fair valuation
High dividend yield expected
Small challenges to pay loans and raise capital
buy
Mediclin AG

Start price
Target price
Perf. (%)
€4.36
10.01.21
€6.00
10.01.22
-15.14%
11.01.22

EBIT growth >5% per year expected
positive Cash Flow expected
Top 10 in its market
Future proof or reliable business model
buy
4 SC AG

Start price
Target price
Perf. (%)
€2.11
10.01.21
€2.00
10.01.22
-29.15%
11.01.22

Could be worthwhile Investment >10% per year
Standard Investments for future growth
Top 10 in its market
Known brand
buy
Evotec SE

Start price
Target price
Perf. (%)
€28.90
06.01.21
€40.00
-1.18%
10.03.21

Medium risks for its business
buy
Fresenius SE & Co. KGaA

Start price
Target price
Perf. (%)
€39.22
04.01.21
€75.00
04.01.22
11.33%
05.09.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Higher EBIT margin than peer group
buy
Stratec SE

Start price
Target price
Perf. (%)
€122.40
30.12.20
€128.00
30.12.21
12.75%
31.12.21

Could be worthwhile Investment >10% per year
buy
Fresenius SE & Co. KGaA

Start price
Target price
Perf. (%)
€37.29
21.12.20
€42.00
-3.06%
01.02.21

buy
Bayer AG

Start price
Target price
Perf. (%)
€48.85
19.12.20
€62.00
22.06.21
7.59%
22.06.21

Undervalued
Well known brand
Future proof or reliable business model
Top 10 in its market
buy
Medigene AG

Start price
Target price
Perf. (%)
€3.56
18.12.20
-
18.12.21
8.86%
27.02.21

Innovative
Dependend from some customers or products
Higher risks for its business
buy
Bayer AG

Start price
Target price
Perf. (%)
€49.67
18.12.20
€57.00
18.12.21
3.14%
09.07.21

Undervalued
Risky Investment
buy
Bio-Gate AG

Start price
Target price
Perf. (%)
€4.36
13.12.20
-
13.12.21
-5.96%
10.01.21

Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies